Pacific Mesothelioma Center Board of Directors
As a division of the Pacific Heart, Lung & Blood Institute, the Pacific Mesothelioma Center (PMC) is governed by a volunteer Board of Directors comprised of community leaders, patients and family members of mesothelioma patients.
Our Board Members include:
Douglas Gamble – Director
Douglas Gamble is the international vice president of the western states conference of the heat and frost insulators and allied workers international union (formerly referred to as the Asbestos Workers union). His father started working as an Asbestos Worker in October 1941 in the naval shipyard in Bremerton, Washington. Douglas first worked in the Asbestos Worker trade in June of 1968 as a helper. He has personal experience with asbestos exposure, having lost both his father to mesothelioma in 1980 and his brother in-law in 1996. Many of his co-workers and friends have faced mesothelioma with courage and a will to fight for their life. He is totally committed to assisting in any way possible to raise awareness, increase research and making the latest treatment options accessible to those affected with mesothelioma.
Dr. Warren S. Grundfest is the former Chair of Biomedical Engineering at UCLA where he holds appointments as Professor of Bioengineering, Electrical Engineering and Surgery. He serves as the Senior West Coast Clinical Advisor and Portfolio Manager for Nanomedicine and Biomaterials for TATRC (the Telemedicine and Advanced Technology Research Center of the U.S. Army). He serves as a Panel Member for several NIH Study Sections, and FDA and DoD review committees. He is one of the nation’s foremost experts on image-guided therapies and medical device development. His research interests include minimally invasive surgery, optical diagnostics, medical robotics, and advanced medical imaging technologies. Dr. Grundfest is past President of IMBISPS, a Fellow of the American College of Surgeons, the AIMBE, and SPIE. He holds 15 patents, has 5 more pending, and has authored 200+ papers and 46 book chapters. He has been involved with multiple corporate and venture technology development programs.
Brent is the Co- Founder, Chairman and Chief Investment officer of Grange Capital, a Registered Investment Advisor. He is also Founder and Chief Investment Officer of Elk Rock Capital, an Alternative (Hedge) Investment Fund in Lake Oswego, Oregon.
He is responsible for oversight of portfolio management for all client accounts. As head of the investment team, Brent also leads all research efforts on Grange’s coverage universe and has oversight of the firm’s trading operations.
Prior to co-founding the firm, Brent spent 16 years with Merrill Lynch and 3 years with Union Bank of Switzerland as Senior Vice President, managing portfolios for high net worth individuals, retirement plans and institutions.
Brent attended Portland state University, where he earned a Bachelor of Science in Business Administration (BSBA).
His passions are his two daughters, pursuing the defeat of Mesothelioma, his business, fly fishing and heli-skiing.
Dr. Ozanian is the recipient of numerous awards and accolades to PMC’s Board of Directors, who brings expert guidance in health policy and military healthcare to fight mesothelioma. Rhonda recently moved to Los Angeles from Washington D.C. where she was a 2010-2012 Robert Wood Johnson Foundation Health Policy Fellow, working first in the U.S. Senate and then at the Brookings Institution. She is a veteran, having previously served as a U.S. Air Force Lieutenant Colonel in the Department of Defense and the Senior Policy Analyst to the Assistant Secretary. Deployed to Afghanistan in 2006, she served in 2007 on the President’s Commission for Care of America’s Returning Wounded Warriors. She has amassed over a million dollars in funding for innovative technology programs in healthcare, including veteran services.
Dr. Ozanian’s diverse experiences, including her military background, are a vital addition to both PMC and the EZ Mesothelioma Treatment and Research Center. “Dr. Ozanian brings a rare combination of professional talents combined with a deep personal commitment to healthcare, especially for the many veterans who have unselfishly served their country but now face combat-related health crises such as mesothelioma,” said Dr. Robert B. Cameron, MD, a Scientific Advisor at PMC. “With her insight, compassion, and expertise, PMC is pleased to have her on the Board as it forges ahead in finding better treatments for mesothelioma.”
Dr. Ozanian is also a National Association of Corporate Directors (NACD) Governance Fellow. She has demonstrated her commitment to boardroom excellence by completing NACD’s comprehensive program of study for corporate directors. She supplements her skill sets through ongoing engagement with the director of community and has access to leading practices.
Radha A. Savitala joined the Board of Pacific Heart, Lung & Blood Institute (PHLBI) in June, 2016. With over 13 years of deep industry knowledge, experience in advising and counseling senior executives & board members, and a passion for healthcare, Radha brings a fresh perspective with her years of extensive expertise in business operations and development to the Board of PHLBI.
Radha obtained her law degree from Southwestern University and during her education, she worked in various aspects of healthcare including public interest, California Attorney General’s office and at the federal level. Radha currently serves as Deputy General Counsel for Prime Healthcare and is responsible for mergers and acquisitions and several other aspects of operations for hospitals and medical groups nationwide.
Radha’s passion for a career in law was inspired by her grandfather who was a guiding figure in her life who encouraged her into higher education. Growing up in Orange County, California, Radha knew healthcare was her passion and soon realized that law was a path to healthcare operations. Radha enjoys traveling, outdoor activities and spending time with her family & friends.
Alexa has held numerous public and private board directorships in the UK and US. She has extensive experience chairing board committees including chairing board finance, remuneration and audit committees.
Alexa is also an experienced CEO and senior executive. She has successfully grown and streamlined technology and healthcare businesses in the international arena. With over 25 years’ experience developing and applying new technology, Alexa has worked at leading technology companies Hughes Space and Communications, The Aerospace Corporation, Discovery Communications, and Grandeye.
Alexa’s commitment to improving healthcare includes serving a 5-year role as non-executive director of Central London Community Healthcare NHS Trust, an organization with more than 180 services including running hospitals, community nursing, prison healthcare, and nursing homes. Prior to that she was a partner at Circle from 2005-2007, where she personally negotiated Circle’s successful acquisition of Nations Healthcare.
Alexa’s commercial strengths also draw from her experience in finance. Alexa was previously an investment banker with Goldman Sachs and Credit Suisse, and also worked in private equity and venture capital. Alexa holds an MBA from Harvard Business School and two master’s degrees in engineering from the University of Michigan.
Are you interested in applying your expertise to help the Pacific Mesothelioma Center efforts in finding better treatments for mesothelioma?
Contact executive director Clare Cameron at firstname.lastname@example.org or (310) 478-4678.